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Abstract 
Structural data on the Ca2+-ATPase of sarcoplasmic reticulum are integrated with kinetic data on Ca 2+ transport. The emphasis is 
upon ATPase-ATPase interactions, the requirement for phospholipids, and the mechanism of Ca 2+ translocation. The possible role of 
cytoplasmic [Ca 2+ ] in the regulation of the synthesis of Ca2+-ATPase is discussed. 
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1. Introduction 
The Ca2+-ATPases of sarco/endoplasmic reticulum 
(SERCA) form a family of structurally and functionally 
related enzymes, that catalyze the ATP-dependent translo- 
cation of Ca 2+ from the cytoplasm into the lumen of 
sarco/endoplasmic reticulum, and maintain the resting 
cytoplasmic [Ca 2+ ] in muscle and non-muscle cells at 
levels below 0.1 I~M. 
Since their discovery three decades ago [1,2], there was 
impressive progress in the analysis of the structure and 
function of Ca2+-ATPases [3] that provided a general 
kinetic model of the mechanism of Ca 2+ transport [4,5] 
and established its approximate relationship to the struc- 
ture of the enzyme derived from amino acid sequence and 
secondary structure prediction [6], mutagenesis [6,7], elec- 
tron crystallography [8,9], X-ray and neutron diffraction 
[10] and spectroscopic data [8,11,12]. 
The aim of this review is to summarize selected aspects 
of this progress, highlighting areas of uncertainties, and 
opportunities for future work. 
2. The structure of Ca 2 +-ATPase 
According to the E~-E 2 model of Ca 2+ translocation 
[4], the Ca2+-ATPase alternates between two major struc- 
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tural states during Ca 2+ transport. In the E I state(s) the 
enzyme binds 2 Ca 2+ ions with high affinity (K D = 10 -7 
M) from the cytoplasm, and can be phosphorylated by 
ATP, but not by inorganic phosphate. The Ca 2 + dependent 
phosphorylation of the enzyme by ATP on Asp351 initi- 
ates the translocation of Ca 2+ across the membrane ac- 
companied by conversion of the phosphoenzyme into the 
E 2 states. The E 2 states are characterized by Ca 2+ binding 
sites of low affinity (K  D = 10 -3 M) accessible from the 
lumen of sarcoplasmic reticulum, and reactivity with inor- 
ganic phosphate, but not with ATP. These key features are 
shared by all current models of Ca 2+ transport, although 
they differ significantly in details [4,5]. 
As predicted by the Ej-E 2 model, the equilibrium be- 
tween the various enzyme states can be shifted by the ion 
composition of the medium. Ca 2+ or lanthanides stabilize 
the E j state, and promote crystallization of CaZ+-ATPase 
in a P1 type space group with ATPase monomers as 
structural units [13]. Inorganic phosphate or vanadate in a 
Ca 2 +-free medium, stabilizes the Ca2+-ATPase in the E 2 
state and induces the formation of distinct P2 type Ca 2+- 
ATPase crystals, with ATPase dimers as structural units 
[14-23]. The Ca2+-ATPase was also crystallized from 
detergent solutions in the presence of 20-40 mM Ca 2+ 
forming multilamellar arrays with a probable space group 
of C 12 [24-26]. 
There are different interactions between ATPase 
molecules in the E 1 and E 2 crystals [9] indicating distinct 
conformations. This conclusion is supported by different 
112 A.N. Martonosi / Biochimica et Biophysica Acta 1275 (1996) l l l - l  l 7 
effects of membrane potential [ 13,17,27], high hydrostatic 
pressure [28-30], tryptic proteolysis [13,15,31] and vana- 
date catalyzed photocleavage [32,33] on the enzyme in the 
Ej and E 2 states, together with differences in tryptophan 
fluorescence [8,34], protein dynamics measured by fluores- 
cence energy transfer [35] and reactivity with monoclonal 
antibodies [36,37]. The E 1 and E 2 type crystals can be 
reversibly interconverted by changes in the Ca 2+ concen- 
tration of the medium and in membrane potential [13]. 
Despite these structural differences the low resolution pro- 
file of Ca2+-ATPase seen in the three crystal forms is 
similar, consisting of a large cytoplasmic domain, a con- 
necting stalk, and an intramembrane domain, confirming 
the lollipop structures een in early negatively stained 
[38,39] and freeze-fractured [40] electron micrographs of 
sarcoplasmic reticulum. Based on predictions from the 
primary structure of Ca2+-ATPase [41], and from extensive 
site specific mutagenesis [6,7] and chemical modification 
studies (for review, see [8]), the cytoplasmic domain con- 
tains the active sites of ATP hydrolysis and phosphoryla- 
tion while the Ca 2+ channel is assigned to the transmem- 
brane domain consisting of l0 putative helical segments 
(Mi-Mto). Some Ca 2+ binding sites may also be located 
near the cytoplasmic and lumenal surfaces of the mem- 
brane [ 10,42]. 
The model of Ca2+-ATPase based on these data does 
not yet permit precise localization of the functional sites. 
Nevertheless it appears probable that phosphorylation of
Asp351 in the cytoplasmic domain is coupled to Ca 2+ 
translocation across the transmembrane domain by ° long- 
range structural change over distances of 30-40 A. One 
manifestation of this is the deeper immersion of the Ca 2+- 
ATPase into the lipid bilayer of the membrane in the E 2 
conformation of the enzyme, as is suggested both by 
electron crystallographic [43] and X-ray data [44]. A flexi- 
ble region of the CaZ+-ATPase between the ATP binding 
domain and the putative Ca 2+ channel was identified by 
the temperature d pendence of normalized energy transfer 
between fluorophores attached at different locations in the 
ATPase molecule [35] that may serve as the conduit of the 
coupling process. 
The circular dichroism spectra of Ca2+-ATPase in the 
E I and E 2 states are similar [45], suggesting that the 
conformational coupling during EI -E  2 transition occurs by 
a rearrangement of protein domains through hinge-type or 
sliding motions, without major changes in secondary struc- 
ture. 
These spectroscopic, electron crystallographic or lamel- 
lar X-ray diffraction techniques are not likely to provide an 
atomic resolution structure of Ca 2 +-ATPase that is a neces- 
sary condition for further progress in this area. High 
resolution X-ray crystallography on CaZ+-ATPase crystals 
representing the different structural states of the enzyme 
during Ca 2+ transport will be required to gain further 
insight into the molecular basis of ATP dependent Ca 2+ 
translocation. 
3. The physiological significance of ATPase oligomers 
It is generally accepted based on electron microscope 
[46-48] and fluorescence energy transfer data [49,50] that 
the ATPase molecules form dimers and higher oligomers 
both in the native sarcoplasmic reticulum membranes, and 
in reconstituted Ca2+-ATPase proteoliposomes. ATPase- 
ATPase interactions were also observed in detergent solu- 
tions of Ca2+-ATPase by exclusion chromatography and 
chemical crosslinking [51 ]. 
While monomeric Ca2+-ATPase in detergent solutions 
can carry out most elementary steps of Ca 2+ stimulated 
ATP hydrolysis [51], it differs from the oligomeric enzyme 
of the native membrane by loss of its cooperativity to 
[Ca 2+ ] and [ATP], and by increased sensitivity to denatura- 
tion at low Ca 2+ concentrations where the oligomeric 
enzyme is quite stable. The stability of Ca2+-ATPase in 
the native membrane is presumably due to the formation of 
ATPase dimers, that are linked by a massive protein bridge 
and interact with adjacent ATPase dimers both in the 
bilayer domain and in the cytoplasm [19,20]. 
The physiological significance of ATPase-ATPase in- 
teractions is manifested in the highly cooperative depen- 
dence of Ca :+ transport on cytoplasmic Ca 2+ concentra- 
tion during relaxation of frog skeletal muscle with a Hill 
coefficient of = 4, that implies ATPase dimers as func- 
tional units of Ca 2+ transport in vivo [52]. It would be 
interesting to know whether the increase in cytoplasmic 
Ca 2+ concentration during muscle contraction produces a
similar change in ATPase-ATPase interactions, as seen 
during the reversible conversion of E 2 type into Ej type 
Ca2+-ATPase crystals by increasing the medium Ca 2+ 
concentration i  vitro [13]. 
Based on phosphorescence anisotropy measurements, a 
correlation was suggested between the aggregation state of 
Ca2+-ATPase in isolated sarcoplasmic reticulum vesicles 
and the inhibition of ATPase activity by phospholamban 
[53], cyclopiazonic acid [54], thapsigargin [55], hexanol 
[56], lidocaine [57], and melittin [58]. The proposed role of 
ATPase aggregation in the effects of melittin was not 
confirmed by other investigators [59]. It appears unlikely 
that the diverse inhibitors listed above would inhibit AT- 
Pase activity by a single common mechanism. 
4. ATPase-ATPase interactions and the morphogenesis 
of sarcoplasmic reticulum 
In pectoralis muscles of chicken embryos, the sarco- 
plasmic reticulum is distributed in the cytoplasm in the 
form of smooth and rough surfaced vesicles [60] that 
contain very little Ca2+-ATPase [61]. As development 
proceeds the vesicular sarcoplasmic reticulum is trans- 
formed into long, slender tubules of about 900 ,~ diameter 
accompanied by a 20-40 fold increase in Ca2+-ATPase 
content [60,61 ]. Long cylindrical tubules of similar dimen- 
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sions also develop from isolated sarcoplasmic reticulum 
vesicles in Ca 2+ -free solution in the presence of vanadate 
or inorganic phosphate during the formation of E 2 type 
Ca2+-ATPase membrane crystals [14,16,18,19)], raising 
the possibility that the tubular morphology of longitudinal 
sarcoplasmic reticulum in mature muscle arises as a result 
of ATPase-ATPase interactions. This possibility was tested 
by fusing sarcoplasmic reticulum vesicles into giant spheri- 
cal proteoliposomes of 1-25 Ixm diameter in the presence 
of polyethylene glycol, followed by addition of vanadate 
or inorganic phosphate in a Ca 2+ -free medium [62]. As 
the Ca 2~ -ATPase crystals began to appear, the membrane 
of the giant vesicles assumed acorrugated appearance with 
the formation of crystalline ridges, separated by deep 
furrows, that eventually pinched off forming olong crys- 
talline tubules of approximately 900-1000 A diameter 
[62]. In the crystalline tubules, dimer chains of ATPase 
molecules are wound around the membrane with a pitch of 
about 57 ° interacting with neighboring dimer chains by 
primary contacts within the bilayer. The massive protein 
bridges between the ATPase molecules forming a dimer 
[19] are oriented parallel with the long axis of the crys- 
talline tubules. Additional cytoplasmic ontacts link the 
dimers into the long dimer chains. These four types of 
interactions between ATPase molecules appear to be the 
principal organizing forces that determine the tubular shape 
of longitudinal sarcoplasmic reticulum. The relatively high 
concentration of inorganic phosphate (3 raM), together 
with the low Ca 2. concentration i  resting skeletal muscle 
may stabilize these interactions. It remains to be deter- 
mined whether there are changes in the morphology of 
longitudinal sarcoplasmic reticulum tubules during pro- 
longed contractile activity when the Ca 2+ concentration f
cytoplasm may become sufficiently elevated to disrupt he 
protein bridges that stabilize the ATPase dimers. The 
distinct morphology of the terminal cisternae despite their 
high Ca2+-ATPase content may be due to the presence of 
other proteins, and the unique morphology of the junc- 
tional face membrane to which it is attached. 
can be extracted by detergents without inhibition of AT- 
Pase activity, and that a 'lipid annulus' formed by the 
remaining 30 phospholipid molecules around the Ca 2+- 
ATPase determines the ATPase and Ca 2+ transport activi- 
ties of the enzyme. There are no significant differences in 
the rate of extraction of phosphatidylcholine, phosphatidyl- 
serine, and phosphatidylethanolamine from the membrane 
by cholate, deoxycholate and C I2E 8 [64], contradicting 
recent claims [66] of preferential retention of tightly bound 
phosphatidylethanolamine and phosphatidylserine by the 
Ca 2+ -ATPase during extraction of the membrane by C 12 Es. 
As the phospholipid molecules at the protein-lipid inter- 
face are in rapid equilibrium with the bulk phospholipids 
in the bilayer [67] there is no evidence for an "annular 
lipid layer" of unique stoichiometry, composition or ki- 
netic properties interacting with the Ca 2 + ATPase. 
The kinetic characteristics of the Ca2+-ATPase are de- 
termined largely by the physical properties of the bilayer 
phospholipids [68]. The inhibited ATPase activity of lipid 
depleted sarcoplasmic reticulum can be restored to control 
levels by micellar dispersions of a variety of phospho- 
lipids, lysophospholipids, fatty acids and detergents [63,64], 
indicating that the phospholipid requirement of Ca 2+- 
ATPase is relatively nonspecific, 
The proportional inhibition of ATPase activity by the 
removal of membrane phospholipids i  probably due to 
aggregation of ATPase molecules in the shrinking mem- 
brane, The density of Ca2+-ATPase in sarcoplasmic reticu- 
lure of fast-twitch skeletal muscle is = 30000 ATPase 
molecules/ixm 2 surface area; therefore the ATPase 
molecules are on the average only a few hundred .~ apart. 
Extraction or hydrolysis of membrane phospholipids de- 
creases the surface area of the membrane [69] and forces 
the ATPase molecules into tight aggregates with progres- 
sive loss of the conformational flexibility required for ATP 
hydrolysis and Ca 2+ transport [70]. Such a mechanism 
applies also to the inhibition of ATPase activity in recon- 
stituted ATPase-dipalmitoylphosphatidylcholine vesicles 
below the transition temperature [71] where phase separa- 
tion promotes the formation of ATPase aggregates [72]. 
5. The phospholipid requirement of Ca z + transport 
The sarcoplasmic reticulum membranes contain about 
100 phospholipid molecules per Ca~-+-ATPase. About one 
third of the protein mass of the Ca2+-ATPase is immersed 
into the lipid bilayer [20] and the ATPase and Ca 2+ 
transport activity of Ca2+-ATPase is absolutely dependent 
on membrane phospholipids [63]. Depletion of the 
phospholipid content of sarcoplasmic reticulum by hydrol- 
ysis with phospholipases or by extraction with detergents 
reversibly inhibits ATP hydrolysis and Ca 2. transport, and 
the inhibition increases in exact proportion to the decrease 
in the phospholipid content of the membrane [64]. These 
observations conflict with earlier claims [65] that about 
70% of the phospholipid content of sarcoplasmic reticulum 
6. The Ca z+ channel(s) of the CaZ+-ATPase 
6.1. Is the translocation o f  m,o Ca 2 + ions sequential  or  
non-sequent ia l  ? 
The Ca'-+-ATPase binds two Ca 2+ ions with high affin- 
ity (K D = 10 -7 M) from the cytoplasm at Ca 2+ sites 
presumed to be located in the transmembrane domain. The 
entry of the two Ca 2+ ions into these sites is sequential 
and cooperative, and they are freely exchangeable with 
Ca 2+ in the cytoplasm [73]. Phosphorylation of the en- 
zyme by ATP renders the two bound Ca 2 + non-accessible 
to the cytoplasmic medium [73], but there is disagreement 
about he mechanism of the subsequent s eps involving the 
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translocation of the two Ca 2+ ions across the membrane 
[73-76]. 
According to Inesi [73] and Forge et al. [74], the two 
Ca 2+ ions pass through the putative Ca 2+ channel sequen- 
tially in single file; the first Ca 2+ that entered the channel 
from the cytoplasmic side is the first to exit on the lumenal 
side of the membrane followed by the other Ca 2+. 
Two other groups [75,76] found that instead of the 
sequential translocation suggested by Inesi [73], the two 
Ca 2+ ions become indistinguishable as they dissociate 
from the Ca2+-ATPase into the lumen of sarcoplasmic 
reticulum. 
It remains to be determined whether the different results 
are due to differences in technique or represent a funda- 
mental disagreement. Resolution of the sequential release 
of two Ca 2+ ions may require conditions that maximize 
the differences between the affinity of the two Ca 2 + ions 
for the enzyme and provide optimal resolution of the 
kinetics of a single catalytic ycle [77]. 
6.2. Are  there two or  .four Ca e+ sites in the Ca 2+ 
channel?  
According to the standard E~-E 2 model the Ca 2+ bind- 
ing sites of the Ca2+-ATPase alternate between states of 
high affinity (E~, E 1 ~ P) and low affinity (E 2 ~ P, E 2) for 
Ca 2 +. Based on this model, high concentration of Ca 2+ in 
the lumen of sarcoplasmic reticulum should shift the Ej 
E e equilibrium in favor of the E 2 state and should inhibit 
the Ca 2+ dependent phosphorylation of the enzyme by 
ATP on the cytoplasmic side. However Jencks and his 
colleagues [78,79] found no difference between empty and 
Ca2+-loaded vesicles in the rate and [Ca R+ ] dependence of
enzyme phosphorylation by ATP, suggesting that the same 
low affinity sites were occupied by Ca 2 + both in the free 
enzyme and in the phosphoenzyme. They concluded [79] 
that the cytoplasmic and lumenal Ca 2 + binding sites of the 
Ca2+-ATPase are distinct and independent, in contrast o 
predictions based on the E j -E  2 model. In the four Ca :+ 
site model proposed by Jencks et al. [78,79], the two Ca: + 
ions bound initially to the high affinity cytoplasmic Ca 2+ 
binding sites are translocated after phosphorylation of the 
enzyme by ATP to distinct low affinity lumenal sites, 
followed by non-sequential Ca 2+ release into the lumen of 
sarcoplasmic reticulum. Jencks and his colleagues also 
suggested that there is only one form of Ca 2 E ~ P and the 
ADP-insensitive phosphoenzyme f atured in the standard 
E j -E  2 model is actually Ca-free E ~ P [80]. 
A four Ca :+ site model was also considered by 
Meszaros and Bak [81,82] based on evidence that there 
was no detectable lag phase in the uptake of Ca 2+ by 
sarcoplasmic reticulum vesicles after the addition of ATP 
to the Ca-enzyme complex. A lag phase would be expected 
if after the translocation of already bound Ca 2+, the en- 
zyme would have to return from the low affinity E 2 state 
into the El state before it can bind Ca 2"- again to the high 
affinity Ca 2+ binding sites. They argued [81,82] that in 
contrast to the E j -E  2 model, the Ca 2+ binding sites do not 
alternate between high and low affinity states but that after 
phosphorylation the two Ca 2+ ions move from the high 
affinity sites to preexisting low affinity sites and the 
vacated high affinity sites are rapidly refilled by Ca 2+. 
It is unclear how four Ca 2+ sites could fit into a single 
Ca 2+ channel and be occupied by four Ca 2+ ions without 
prohibitive lectrostatic constraints. Furthermore, there are 
several observations that are not readily reconcilable with 
the four Ca 2. site hypothesis. 
FTIR spectra of sarcoplasmic reticulum obtained before 
and after Ca 2+ release by photolysis of caged-Ca ~+ indi- 
cate a decrease in absorbance at 1650-1653 cm -j  and an 
increase in absorbance at 1663 cm-~ and 1676 cm-~ due 
to Ca 2+ binding to the high affinity Ca 2+ sites of the 
Ca 2+-ATPase [I 1,12,83]. These changes were prevented 
by agents (EGTA, vanadate, dicyclohexylcarbodiimide) 
that inhibit Ca 2+ binding to the Ca2+-ATPase. 
The Ca 2+-induced changes in FTIR spectra were re- 
versed by photolysis of caged-ATP in a Ca2+-containing 
medium [9,12]. These data [9,11,12] suggest, in agreement 
with the standard E t -E  2 model, that phosphorylation of
Ca2+-ATPase by ATP converted the high affinity Ca 2+ 
sites into sites of low affinity. The ATP- induced reversal 
of the CaZ+-induced change in IR absorbance persisted as 
long as ATP was present, indicating that the high affinity 
Ca 2+ sites were not refilled by Ca :+ from the cytoplasmic 
medium. Therefore during steady state the dominant en- 
zyme form was E ~ P of low Ca 2+ affinity that did not 
bind Ca 2. at the high affinity Ca e+ site, in conflict with 
the four Ca 2~ site hypothesis. These observations are 
supported by the kinetic data of Ikemoto [84] that indicate 
Ca 2+ release from the Ca2+-ATPase after phosphorylation 
by ATP; the rebinding of Ca 2 + to the Ca 2+-ATPase took 
place only after the hydrolysis of the phosphoenzyme 
intermediate. The data of Ikemoto [84] show a delay of as 
much as 50 ms between phosphoenzyme formation and 
Ca -'~ release from the Ca2+-ATPase, without any indica- 
tion of Ca 2+ rebinding to the phosphorylated nzyme, in 
conflict with the data of Meszaros and Bak [81,82]. Even 
greater delay between E ~ P formation and Ca R+ uptake 
was observed using ITP as substrate [85]. 
6.3. A l ternat ive  Ca e + channel  mechan isms 
Based on secondary structure predictions the transmem- 
brane domain of Ca2+-ATPase is assumed to contain l0 
helices (Mi-Mlo) [6,7]. Mutagenesis of five amino acids 
in helices M4, M5, M6 and M8 interfered with high 
affinity Ca 2+ binding suggesting that these four helices 
may contribute to the Ca 2 + channel(s) of the Ca 2 +-ATPase. 
Recent data also implicate the M 3 helix in high affinity 
Ca 2+ binding and thapsigargin sensitivity, and suggest that 
the effects of mutations on the two high affinity Ca 2+ sites 
can be separated [7]. In the absence of high resolution 
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structural data the degree of freedom in the interpretation 
of these results is great. In addition to the conventional 
single channel model with the two Ca 2+ binding sites 
arranged in single file, other models are also possible. 
6.3.1. The two channel hypothesis 
As an alternative possibility we propose a model of two 
interacting Ca 2+ channels gated by the phosphorylation f 
the CaZ+-ATPase at a single site (Asp351). One of these 
channels could be formed by helices M 2, M~, M 4 and M 5, 
and the other by helices M4, Ms,  M 6 and M s based on the 
tentative arrangement of these helices in the transmem- 
brane domain [23]. Each of the two channels may contain a 
single Ca 2+ binding site that alternates between high and 
low affinity states in accordance with the conventional 
E~-Ez model. The existence of two distinct but interre- 
lated Ca 2+ channels may help to explain the selective loss 
of one of the two Ca 2 + binding sites caused by thapsigar- 
gin that occurs with loss of cooperativity, but without 
major change in the Ca 2+ affinity of the second site [86], 
and the kinetic differences between Ca 2 +-ATPases contain- 
ing one or two bound Ca 2+ or Sr 2+ ions [87,88]. 
6.3.2. Variable stoichiomet~ of the Ca2 + binding site 
Changes in the affinity of the Ca 2+ binding sites may 
result from changes in Ca2+-hinding stoichiometry. As an 
example, the L type Ca 2+ channels are assumed to contain 
a Ca 2-~ binding site formed by four glutamate residues that 
bind one Ca :+ with high affinity (K  D = 1 txM) or two 
Ca 2+ with low affinity (K D = 14 mM) [89]. The contribu- 
tion of the four carboxylate groups to the Ca 2+ binding is 
non-equivalent. The outermost carboxylate groups are sug- 
gested to draw the second Ca 2+ into the binding locus by 
electrostatic nteraction [89]. In adapting this model to the 
Ca2+-ATPase, one may assume that one Ca 2+ is bound 
with high affinity (K D = 10 -7 M) at each of two sites in 
the absence of ATP, with free exchange between bound 
Ca 2+ and the cytoplasmic Ca 2+. Upon phosphorylation f
CaZ+-ATPase a second Ca 2+ would enter into each site 
causing a decrease in Ca 2+ affinity (K D = 1 mM), and 
closure of the cytoplasmic hannel gates. Since the domi- 
nant intermediate during Ca 2 + transport at steady state has 
low Ca 2+ affinity, the rate of Ca 2+ release into the lumen 
of sarcoplasmic reticulum may be determined by subse- 
quent slow reaction steps. 
The choice between the various possible Ca 2+ translo- 
cation mechanisms requires more information about the 
structure of the Ca 2+ channel than currently available. 
7. Regulation of the expression of CaZ+-ATPase by 
calcium 
Finally, one of the most interesting problems for future 
studies is the regulation of the expression of the Ca 2+- 
ATPase gene during development and in response to mus- 
cle activity. 
During development of skeletal muscle, the Ca 2÷- 
ATPase content of sarco/endoplasmic reticulum increases 
from 1-2% to about 80% of the total protein content 
within a few weeks [60,61,90,91]. The fiber type specific 
expression of distinct isoforms of the Ca2+-ATPase is 
controlled by promoter and enhancer elements in the regu- 
latory regions of their respective genes [92-97], under the 
influence of a variety of transcriptional regulators that 
include myogenin [95]. 
Exposure of cultured muscle cells to low concentrations 
of Ca 2+ ionophores causes increased synthesis of Ca 2+- 
ATPase [98,99], and of several chaperone proteins includ- 
ing GRP78 [91,100-102]; this is accompanied by an in- 
crease in cytoplasmic Ca 2+ concentration [103]. Based on 
these observations, we suggested [90,91] that regulation of 
gene expression by Ca 2+ through nuclear Ca 2+ binding 
proteins [104] plays a role in the modulation of Ca 2+- 
ATPase synthesis during development, and in the adapta- 
tion of sarcoplasmic reticulum to the activity pattern of 
muscle [105] in the adult animals. 
In recent years this proposition gained further support 
with the demonstration of increased expression of Ca 2+- 
ATPase and GRP78 in cells treated with thapsigargin 
[106-108], and with accumulating evidence on the role of 
electrical activity and Ca 2+ in the expression of acetyl- 
choline receptor [109,110], and other proteins [111,112]. 
Certain chaperone proteins interact with the muscle spe- 
cific transcriptional regulator myoD [113], raising the pos- 
sibility that the coexpression of Ca2+-ATPase [98,99] with 
the chaperone protein GRP78 [91,100,101] observed in 
cells treated with Ca 2+ ionophores may be actually part of 
the normal process of myogenesis. Our increasing knowl- 
edge of myogenic transcriptional regulators [114], and of 
the role of Ca 2+ signalling in cell proliferation and differ- 
entiation [115,116] provide the necessary framework for 
the analysis of the mechanism of Ca ~-+ effect on the 
synthesis of Ca 2 +-ATPase. 
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